A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis

被引:0
作者
Hongdi Ma
Taidou Hu
Wanyin Tao
Jiyu Tong
Zili Han
Dietmar Herndler-Brandstetter
Zheng Wei
Ruize Liu
Tingyue Zhou
Qiuyuan Liu
Xuemei Xu
Kaiguang Zhang
Rongbin Zhou
Judy H. Cho
Hua-Bing Li
Hailiang Huang
Richard A. Flavell
Shu Zhu
机构
[1] University of Science and Technology of China,Department of Digestive Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[2] University of Science and Technology of China,Institute of Immunology, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine
[3] Yale University School of Medicine,Department of Immunobiology
[4] Harvard Medical School,Analytic and Translational Genetics Unit, Massachusetts General Hospital
[5] The First Affiliated Hospital of Anhui Medical University,The Key Laboratory of Digestive Diseases of Anhui Province, Department of Gastroenterology
[6] Yale School of Medicine,Department of Genetics
[7] Shanghai Jiao Tong University School of Medicine (SJTU-SM),Shanghai Institute of Immunology, Department of Microbiology and Immunology
[8] Yale University School of Medicine,Howard Hughes Medical Institute
[9] University of Science and Technology of China,School of Data Science
[10] Hefei Comprehensive National Science Center,Institute of Health and Medicine
来源
Cell Research | 2023年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Inflammatory bowel diseases (IBD) are known to have complex, genetically influenced etiologies, involving dysfunctional interactions between the intestinal immune system and the microbiome. Here, we characterized how the RNA transcript from an IBD-associated long non-coding RNA locus (“CARINH-Colitis Associated IRF1 antisense Regulator of Intestinal Homeostasis”) protects against IBD. We show that CARINH and its neighboring gene coding for the transcription factor IRF1 together form a feedforward loop in host myeloid cells. The loop activation is sustained by microbial factors, and functions to maintain the intestinal host-commensal homeostasis via the induction of the anti-inflammatory factor IL-18BP and anti-microbial factors called guanylate-binding proteins (GBPs). Extending these mechanistic insights back to humans, we demonstrate that the function of the CARINH/IRF1 loop is conserved between mice and humans. Genetically, the T allele of rs2188962, the most probable causal variant of IBD within the CARINH locus from the human genetics study, impairs the inducible expression of the CARINH/IRF1 loop and thus increases genetic predisposition to IBD. Our study thus illustrates how an IBD-associated lncRNA maintains intestinal homeostasis and protects the host against colitis.
引用
收藏
页码:372 / 388
页数:16
相关论文
共 115 条
  • [41] Zhang H(2002)Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling Annu. Rev. Immunol. 20 197-216
  • [42] Wang L(1995)The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta Infect. Immun. 63 601-608
  • [43] Maass PG(2014)Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity Nature 509 366-370
  • [44] Fanucchi S(2021)Innate immune recognition Mucosal. Immunol. 14 113-124
  • [45] Czimmerer Z(2019)Differential expression of interferon regulatory factor-1 (Irf-1), Irf-2, and interferon consensus sequence binding-protein genes in lipopolysaccharide (Lps)-responsive and Lps-hyporesponsive macrophages Clin. Exp. Gastroenterol. 12 37-49
  • [46] Chan WI(2002)Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases Scand. J. Gastroenterol. 37 1034-1041
  • [47] Nowarski R(2006)Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation J. Med. Microbiol. 55 617-624
  • [48] Coccia M(2017)Fecal microbiota profiles in treatment-naive pediatric inflammatory bowel disease—associations with disease phenotype, treatment, and outcome Cell Rep. 21 994-1008
  • [49] Mirpuri J(2013)Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls Elife 2 e01202-475
  • [50] Liu L(2015)Prevalence of Bacteroides and Nat. Immunol. 16 467-2854